Lombardi Ronald M. — SEC Form 4 filings
SEC reporting owner CIK 1507111. 26 Form 4 filings on record with FilingPulse; latest filed 2026-09-10.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-03-29 to 2026-09-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 2 filings — 93,112 shares, $7,688,005 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: sale of 48,512 shares @ $82.67 ($4,010,487) in Prestige Consumer Healthcare Inc., filed 2024-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | Chief Executive Officer, Director | 12 | — | 4 legs · 93,112 sh · $7,688,005 | 26 |
| ACCO BRANDS Corp (ACCO) | Director | 14 | — | — | 14 |
Form 4 filings — Lombardi Ronald M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 3,292 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 3,559.80 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 32,809 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Tax withholding (F): 2,543 @ $54.59 | EDGAR |
| 2026-05-07 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Tax withholding (F): 2,197 @ $55.75 | EDGAR |
| 2026-05-06 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Grant/award (A): 31,468 @ $0 · Tax withholding (F): 16,789 @ $55.31 · Grant/award (A): 19,662 @ $0 | EDGAR |
| 2026-05-05 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Tax withholding (F): 2,665 @ $55.09 | EDGAR |
| 2026-03-27 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 3,787.10 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 2,961.70 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 2,716.40 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 3,076.80 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 32,895 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Tax withholding (F): 2,305 @ $81.41 | EDGAR |
| 2025-05-07 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Grant/award (A): 12,352 @ $0 | EDGAR |
| 2025-05-06 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Tax withholding (F): 2,664 @ $84.19 · Tax withholding (F): 2,416 @ $84.19 · Grant/award (A): 39,904 @ $0 · Tax withholding (F): 19,294 @ $82.98 | EDGAR |
| 2025-03-27 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 1,811 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 1,283.40 (derivative) @ $0 | EDGAR |
| 2024-11-21 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Option exercise (M): 5,213 @ $57.18 · Sale (S): 5,213 @ $82.55 · Option exercise (M): 5,662 @ $56.11 · Sale (S): 5,662 @ $82.64 · Option exercise (M): 5,213 (derivative) @ $0 · Option exercise (M): 5,662 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Option exercise (M): 48,512 @ $57.18 · Sale (S): 48,512 @ $82.67 · Option exercise (M): 33,725 @ $56.11 · Sale (S): 33,725 @ $82.41 · Option exercise (M): 48,512 (derivative) @ $0 · Option exercise (M): 33,725 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 1,447.80 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 1,532.30 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 24,951 @ $0 | EDGAR |
| 2024-05-09 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Grant/award (A): 14,298 @ $0 | EDGAR |
| 2024-05-08 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Grant/award (A): 85,533 @ $0 · Tax withholding (F): 41,356 @ $70 | EDGAR |
| 2024-05-06 | 4 | Prestige Consumer Healthcare Inc. (PBH) | Tax withholding (F): 2,664 @ $71.26 · Tax withholding (F): 2,416 @ $71.26 · Tax withholding (F): 3,000 @ $70 | EDGAR |
| 2024-03-29 | 4 | ACCO BRANDS Corp (ACCO) | Grant/award (A): 1,344.60 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1507111 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →